BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 25, 2025
Home » Authors » Randy Osborne

Articles by Randy Osborne

IPO Trend Hasn't Fizzled As TolerRx Plans $75M Offering

Aug. 28, 2003
By Randy Osborne

BioCryst Quits 3-Dimensional Deal To Spend Funds Elsewhere

Aug. 28, 2003
By Randy Osborne

Genentech, PDL Dispute Could Mean Lawsuit Troubles Ahead

Aug. 25, 2003
By Randy Osborne

Cephalon's Hostile Takeover Bid For CIMA Ups The Ante

Aug. 22, 2003
By Randy Osborne

CuraGen Subsidiary Sequences Whole Adenovirus In One Day

Aug. 22, 2003
By Randy Osborne

GTx Financing Pulls Down $20M To Advance Men's Health Drugs

Aug. 21, 2003
By Randy Osborne

MultiCell Pushes Liver Proteins With $18M XenoTech Contract

Aug. 21, 2003
By Randy Osborne

New Interpretation Of SBIR Rules Puts Squeeze On VC-Backed Firms

Aug. 18, 2003
By Randy Osborne
As a bridge over troubled financing waters, Small Business Innovation Research grants have an indisputable value, and the advantages are especially well known to start-up biotechnology companies that have availed themselves of SBIRs. (BioWorld Financial Watch)
Read More

Neurologix, CTP Agree To Merge; Parkinson's Trial Starting Shortly

Aug. 15, 2003
By Randy Osborne

Clearant Financing Gets $18M To Push Pathogen Inactivation

Aug. 14, 2003
By Randy Osborne
Previous 1 2 … 427 428 429 430 431 432 433 434 435 … 465 466 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing